Efectos de los medicamentos estimulantes en el microbiota intestinal de niños con TDAH

Introduction: Pharmacotherapy with stimulants, atomoxetine or guanfacine, has been shown to be effective in reducing the main symptoms of ADHD. Objective: The use of stimulant medications affects the diversity and composition of the intestinal microbiota in children diagnosed with ADHD to better understand the possible side effects of these treatments. Methodology: An observational study is stratified with a descriptive and retrospective study that collects data from various bibliographic sources, and retrospective character that collects data from various bibliographic sources under the PRISMA guidelines. Results: amphetamines (AMPH), aim to increase the concentration of neurotransmitters in the prefrontal cortex. However, it also points out that some medications may have negative side effects, such as changes in the intestinal microbiome. that some medications may have negative side effects, such as changes in the intestinal microbiome. Conclusions: Evidence suggests that patients with ADHD may have lower gut microbial diversity if they take stimulant medications such as methylphenidate and amphetamines for a prolonged period. Evidence suggests that patients with ADHD may have lower gut microbial diversity if they take stimulant medications such as methylphenidate and amphetamines for a prolonged period.

• Yazar: Verdezoto Bueno, Elena Tatiana (author)
• Materyal Türü: bachelorThesis
• Dil: spa
• Baskı/Yayın Bilgisi: 2025
• Konular: MICROBIOTA; TDAH; MEDICAMENTOS ESTIMULANTES; MEDICAMENTOS NO ESTIMULANTES
• Online Erişim: https://dspace.uniandes.edu.ec/handle/123456789/19190